Health System Owned Specialty Pharmacy Alliance (HOSP) has named Tim Affeldt, PharmD, vice president of specialty/infusion operations at Fairview Pharmacy Services, as its new president.
As Washington implements the nation's most lenient policy allowing pharmacists to prescribe mifepristone, a medication used for abortion, other states are considering following suit, The New York Times reported Jan. 7.
Patients on dialysis who take denosumab face a 36% higher risk for major cardiovascular adverse events than patients who take oral bisphosphonates, according to a study published Jan. 6 in Annals of Internal Medicine.
Fosigotifator, an amyotrophic lateral sclerosis drug developed by Calico Life Sciences, a biotech company backed by Google's parent company Alphabet, failed to meet its primary endpoint, according to topline results from the Healey ALS platform trial.
A new study found that the widespread use of pharmaceuticals is introducing toxic "forever chemicals" into U.S. waterways, with large municipal wastewater treatment plants unable to effectively filter them out, The Washington Post reported Jan. 7.
In a move designed to provide continued access to remote healthcare services for millions of Medicare beneficiaries, lawmakers approved a three-month extension of expanded telemedicine coverage, set to last until March 31, The New York Times reported Jan. 6.
CVS Health has announced that starting this year, all commercial prescriptions dispensed through CVS Pharmacy will be contracted through its new CVS CostVantage reimbursement model.
Neumora Therapeutics announced that its antidepressant candidate, navacaprant, did not meet the primary endpoint in a Phase 3 study for major depressive disorder.
Eli Lilly is intervening in a lawsuit filed by a trade group representing compounding pharmacies, aiming to block the FDA's determination that the shortage of its GLP-1 medications, Mounjaro and Zepbound, has ended.
